Analysis of recurrently protected genomic regions in cell-free DNA found in urine
- 17 February 2021
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 13 (581)
- https://doi.org/10.1126/scitranslmed.aaz3088
Abstract
Cell-free DNA (cfDNA) in urine is a promising analyte for noninvasive diagnostics. However, urine cfDNA is highly fragmented. Whether characteristics of these fragments reflect underlying genomic architecture is unknown. Here, we characterized fragmentation patterns in urine cfDNA using whole-genome sequencing. Size distribution of urine cfDNA fragments showed multiple strong peaks between 40 and 120 base pairs (bp) with a modal size of 81- and sharp 10-bp periodicity, suggesting transient protection from complete degradation. These properties were robust to preanalytical perturbations, such as at-home collection and delay in processing. Genome-wide sequencing coverage of urine cfDNA fragments revealed recurrently protected regions (RPRs) conserved across individuals, with partial overlap with nucleosome positioning maps inferred from plasma cfDNA. The ends of cfDNA fragments clustered upstream and downstream of RPRs, and nucleotide frequencies of fragment ends indicated enzymatic digestion of urine cfDNA. Compared to plasma, fragmentation patterns in urine cfDNA showed greater correlation with gene expression and chromatin accessibility in epithelial cells of the urinary tract. We determined that tumor-derived urine cfDNA exhibits a higher frequency of aberrant fragments that end within RPRs. By comparing the fraction of aberrant fragments and nucleotide frequencies of fragment ends, we identified urine samples from cancer patients with an area under the curve of 0.89. Our results revealed nonrandom genomic positioning of urine cfDNA fragments and suggested that analysis of fragmentation patterns across recurrently protected genomic loci may serve as a cancer diagnostic.Keywords
Funding Information
- National Cancer Institute (U01CA243078)
- National Cancer Institute (R01CA223481)
- Science Foundation Arizona (BSP-0542-13)
- Ben and Catherine Ivy Foundation
- Arizona Women’s Board
This publication has 43 references indexed in Scilit:
- Controls of Nucleosome Positioning in the Human GenomePLoS Genetics, 2012
- Noninvasive Identification and Monitoring of Cancer Mutations by Targeted Deep Sequencing of Plasma DNAScience Translational Medicine, 2012
- Maternal Plasma DNA Sequencing Reveals the Genome-Wide Genetic and Mutational Profile of the FetusScience Translational Medicine, 2010
- BEDTools: a flexible suite of utilities for comparing genomic featuresBioinformatics, 2010
- The Sequence Alignment/Map format and SAMtoolsBioinformatics, 2009
- Fast and accurate short read alignment with Burrows–Wheeler transformBioinformatics, 2009
- Murine serum nucleases – contrasting effects of plasmin and heparin on the activities of DNase1 and DNase1‐like 3 (DNase1l3)The FEBS Journal, 2009
- The DNA-encoded nucleosome organization of a eukaryotic genomeNature, 2008
- Genome-wide profiling of salt fractions maps physical properties of chromatinGenome Research, 2008
- Nucleosomal Locations of Dominant DNA Sequence Motifs for Histone–DNA Interactions and Nucleosome PositioningJournal of Molecular Biology, 2004